Polyproline‐Polyornithine Diblock Copolymers with Inherent Mitochondria Tropism
Advanced Materials · 2025-02 · 37 (8)
DOI: 10.1002/adma.202411595 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 10.01.2025. Verfasst von Camilla Pegoraro und 12 weiteren Autor:innen. Beteiligte Einrichtung: Príncipe Felipe Research Center, Polymer Therapeutics Lab., Valencia, 46012, Spain. Hauptthemen laut MEDLINE: Mitochondria, Peptides, Polymers, Drug Carriers. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: European Regional Development Fund, NCD-SWEET beamline at the ALBA Synchrotron Light source in Barcelona, Spain, BioMedPharm.
Abstract (Originalsprache)
Mitochondria play critical roles in regulating cell fate, with dysfunction correlating with the development of multiple diseases, emphasizing the need for engineered nanomedicines that cross biological barriers. Said nanomedicines often target fluctuating mitochondrial properties and/or present inefficient/insufficient cytosolic delivery (resulting in poor overall activity), while many require complex synthetic procedures involving targeting residues (hindering clinical translation). The synthesis/characterization of polypeptide‐based cell penetrating diblock copolymers of poly‐L‐ornithine (PLO) and polyproline (PLP) (PLO n ‐PLP m , n:m ratio 1:3) are described as mitochondria‐targeting nanocarriers. Synthesis involves a simple two‐step methodology based on N‐carboxyanhydride ring‐opening polymerization, with the scale‐up optimization using a “design of experiments” approach. The molecular mechanisms behind targetability and therapeutic activity are investigated through physical/biological processes for diblock copolymers themselves or as targeting moieties in a poly‐L‐glutamic (PGA)‐based conjugate. Diblock copolymers prompt rapid cell entry via energy‐independent mechanisms and recognize mitochondria through the mitochondria‐specific phospholipid cardiolipin (CL). Stimuli‐driven conditions and mitochondria polarization dynamics, which decrease efficacy depending on disease type/stage, do not compromise diblock copolymer uptake/targetability. Diblock copolymers exhibit inherent concentration‐dependent anti‐tumorigenic activity at the mitochondrial level. The diblock copolymer conjugate possesses improved safety, significant cell penetration, and mitochondrial accumulation via cardiolipin recognition. These findings may support the development of efficient and safe mitochondrial‐targeting nanomedicines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Príncipe Felipe Research Center, Polymer Therapeutics Lab., Valencia, 46012, Spain.
- Curapath, Av. Benjamín Franklin, 19, Paterna, Valencia, 46980, Spain.
- Max Planck Institute of Biochemistry, Am Klopferspitz 18, 82152, Martinsried, Germany.
- Centro de Investigación Biomédica en Red en Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, 28029, Spain.
- Príncipe Felipe Research Center, Screening Platform, Valencia, 46012, Spain.
- Latvian Institute of Organic Synthesis, Aizkraukles Street 21, Riga, LV-1006, Latvia.
ORCID-Profile: Camilla Pegoraro, Ekaterina Karpova, Yusuf Qutbuddin, Esther Masiá Sanchis, Pavels Dimitrijevs, Cristián Huck-Iriart, Svetozar Gavrilović, Pavel Arsenyan, Petra Schwille, Carles Felip-León, Aroa Duro-Castano, Inmaculada Conejos-Sanchez, María J Vicent
Förderung
- European Regional Development Fund
- NCD-SWEET beamline at the ALBA Synchrotron Light source in Barcelona, Spain
- BioMedPharm
- HORIZON EUROPE Reforming and enhancing the European Research and Innovation system
- Conselleria de Innovación, Universidades, Ciencia y Sociedad Digital, Generalitat Valenciana
- Ministerio de Ciencia e Innovación
- Fundación Científica Asociación Española Contra el Cáncer
- H2020 Marie Skłodowska-Curie Actions
Zitieren
APA
Pegoraro, C., Karpova, E., Qutbuddin, Y., Sanchis, E. M., Dimitrijevs, P., Huck-Iriart, C., Gavrilović, S., Arsenyan, P., Schwille, P., Felip-León, C., Duro-Castano, A., Conejos-Sanchez, I., & Vicent, M. J. (2025). Polyproline‐Polyornithine Diblock Copolymers with Inherent Mitochondria Tropism. Advanced Materials, 37(8). https://doi.org/10.1002/adma.202411595
Vancouver
Pegoraro C, Karpova E, Qutbuddin Y, Sanchis EM, Dimitrijevs P, Huck-Iriart C, et al. Polyproline‐Polyornithine Diblock Copolymers with Inherent Mitochondria Tropism. Advanced Materials. 2025;37(8). doi:10.1002/adma.202411595
BibTeX
@article{Pegoraro2025,
author = {Pegoraro, Camilla and Karpova, Ekaterina and Qutbuddin, Yusuf and Sanchis, Esther Masiá and Dimitrijevs, Pavels and Huck-Iriart, Cristián and Gavrilović, Svetozar and Arsenyan, Pavel and Schwille, Petra and Felip-León, Carles and Duro-Castano, Aroa and Conejos-Sanchez, Inmaculada and Vicent, María J},
title = {Polyproline‐Polyornithine Diblock Copolymers with Inherent Mitochondria Tropism},
journal = {Advanced Materials},
year = {2025},
volume = {37},
number = {8},
doi = {10.1002/adma.202411595}
}
EUVIMED